Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised comparison of intravaginal APL-202 vs dinoprostone for induction of labour in nulliparous women
2004-000107-18Phase 3Completed
- Sponsor
- Alliance Pharma
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol (2 arms), sponsored by Alliance Pharma. Primary endpoint: Number of vaginal deliveries within 24 hours. Started May 2005; status: completed.
02
Drugs
misoprostol
Beyond the preview
Go deeper on 2004-000107-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000107-18.